Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

SAM Domain-containing Protein 9-like

The SAMD9L gene encodes a cytoplasmic protein that acts as an tumor supressor and is involved in innate immunity. Mutations cause autosomal recessive Ataxia-pancytopenia syndrome and are also associated with various foms of leukemia, hepatocellular carcinoma and, normophosphatemic familial tumoral calcinosis.


Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Research Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA
Research Method Multiplex Ligation-Dependent Probe Amplification
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Ataxia-pancytopenia syndrome



de Jesus AA et al. (2020) Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.

external link

Li CF et al. (2007) Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.

external link

Asou H et al. (2009) Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome.

external link

Li FP et al. (1978) A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy.

external link

Jiang Q et al. (2011) The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.

external link

Chen DH et al. (2016) Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

external link
Update: Aug. 14, 2020
Copyright © 2005-2021 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits